Related Experiment Video
Updated: Oct 1, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
Published on: October 3, 2019
Effects of perindopril on aldosterone production in the failing human heart
Yuji Mizuno1, Hirofumi Yasue, Michihiro Yoshimura
1Division of Cardiovascular Medicine, Kumamoto Aging Research Institute, Kumamoto, Japan. aldo@poppy.ocn.ne.jp
Insights
Angiotensin-converting enzyme (ACE) inhibition with perindopril suppresses cardiac aldosterone production in heart failure patients. This occurs by reducing ACE activity within the heart, indicating aldosterone is activated in failing ventricles.
Area of Science:
- Cardiology
- Pharmacology
- Endocrinology
Background:
- Heart failure is associated with activated cardiac aldosterone production.
- The role of cardiac angiotensin-converting enzyme (ACE) in this process is not fully understood.
- Understanding the mechanisms of aldosterone regulation in heart failure is crucial for therapeutic development.
Purpose of the Study:
- To investigate whether ACE inhibition suppresses cardiac aldosterone production in patients with heart failure.
- To determine the effect of perindopril on cardiac ACE activity and aldosterone levels.
- To explore the relationship between cardiac ACE activity and aldosterone production in the failing heart.
Main Methods:
- A randomized controlled trial involving 41 patients with left ventricular systolic dysfunction.
- Patients were assigned to receive either perindopril (4 mg/day) or a placebo.
- Plasma levels of aldosterone and ACE activity were measured in the anterior interventricular vein, coronary sinus, and aortic root via cardiac catheterization.
Main Results:
- In the placebo group, aldosterone and ACE activity were significantly higher in the anterior interventricular vein and coronary sinus compared to the aortic root.
- Perindopril treatment significantly reduced aldosterone and ACE activity in the anterior interventricular vein and coronary sinus compared to placebo.
- A significant positive correlation was observed between the difference in aldosterone and ACE activity between the anterior interventricular vein and aortic root.
Conclusions:
- Perindopril effectively suppresses cardiac aldosterone production in heart failure patients.
- This suppression is primarily mediated by the reduction of cardiac ACE activity.
- Aldosterone production is activated in the failing ventricle and can be modulated by ACE inhibition.
Abstract:
The present study was designed to examine whether the production of aldosterone from the heart is suppressed by angiotensin-converting enzyme (ACE) inhibition in patients with heart failure. Forty-one patients with left ventricular systolic dysfunction were randomly divided into either the perindopril group (n = 21, perindopril 4 mg/day) or the placebo group (n = 20). Plasma levels of aldosterone and ACE activity were measured in the anterior interventricular vein, coronary sinus, and aortic root during cardiac catheterization. The levels of aldosterone as well as ACE activity were significantly higher at the anterior interventricular vein and the coronary sinus than at the aortic root in the placebo group (aldosterone: 92.1 +/- 9.0 vs 70.6 +/- 8.3 pg/ml [p <0.001]; 90.3 +/- 9.2 vs 70.6 +/- 8.3 pg/ml [p <0.001], respectively; ACE activity: 13.6 +/- 0.8 vs 12.2 +/- 0.7 IU/L [p <0.001], 13.4 +/- 0.8 vs 12.2 +/- 0.7 IU/L [p <0.001], respectively). On the other hand, there were no differences in the levels of aldosterone or ACE activity between the anterior interventricular vein and aortic root or between the coronary sinus and aortic root (aldosterone: 68.1 +/- 8.4 vs 69.9 +/- 9.4 pg/ml [p = NS]; 67.3 +/- 8.9 vs 69.9 +/- 9.4 pg/ml [p = NS], respectively; ACE activity: 9.7 +/- 0.8 vs 9.9 +/- 0.8 IU/L [p = NS]; 9.8 +/- 0.8 vs 9.9 +/- 0.8 IU/L, respectively) in the perindopril group. The levels of aldosterone as well as ACE activity were significantly lower at the anterior interventricular vein and coronary sinus in the perindopril group than in the placebo group. The difference in the level of aldosterone between the anterior interventricular vein and aortic root (Delta aldosterone [anterior interventricular vein - aortic root]) had a significant positive correlation with that of ACE activity (Delta ACE [anterior interventricular vein - aortic root]) (r = 0.536, p <0.001), whereas ACE activity in the aortic root had no significant correlation with either the aldosterone levels in the aortic root or Delta aldosterone (anterior interventricular vein - aortic root). Perindopril suppressed cardiac aldosterone production by mainly suppressing cardiac ACE activity in patients with heart failure. Thus, aldosterone production is activated in the failing ventricle and is suppressed by perindopril mainly via the suppression of cardiac ACE activity in patients with heart failure.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Heart Failure II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
